CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the health care giant struggling on ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for current CEO Karen ...

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

The solid-state batteries hype is fading – prompting auto giants to consider alternatives NOAA releases 2024-25 winter ...

CVS Health tapped industry executive David Joyner to replace CEO Karen Lynch and turn around the struggling business. Joyner took over on Thursday as Lynch stepped down from her position in agreement ...

CNBC's Joe Kernen reports on the latest news.

CVS is naming longtime executive David Joyner as its new chief, replacing Lynch. Joyner has been president of CVS Caremark, ...

CEO Karen Lynch at CVS is out, with company shares down 19% this year and the chain struggling.

Already sick, former patients of the failed kidney and liver transplant units face rejection and despair as they look ...

The U.S. government announced quality ratings for 2025 Medicare health and prescription drug plans on Thursday, the first ...

In an interview earlier this year, CVS Health chief executive officer Karen S. Lynch said the company’s four million Medicare Advantage members “can have access to our Oak Street clinics.” ...